Skip to main content
NIVF logo

NewGenIvf Group Limited

NIVFNASDAQHealthcareMedical Care Facilities

$0.15Today:- (-)1Y −99.24%

As of Oct 22, 2026 close

Market cap
$11.23K
P/E (TTM)
0.00
Forward P/E
-
Dividend yield
-
52-week range
$0.17$19.65
Volume (live)
-
Avg. volume (3M)
21.67M

NewGenIvf Group (NIVF) Income Statement

NewGenIvf Group reported revenue of $4.73M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 13.0% from $5.43M a year earlier. Net income was $9.88M, a net margin of 209.0%. Gross margin was 20.2% and operating margin -226.9%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $962.44K, down 4.7% from the same quarter a year earlier.

NewGenIvf Group Income Statement Analysis

Values in millions USD

Scroll to see more
NewGenIvf Group Limited income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Revenue & Gross Profit
Revenue4.735.435.145.944.12
Cost of Revenue3.773.613.454.413.09
Gross Profit0.961.831.681.541.02
Operating Expenses
Research & Development0.000.000.000.000.00
Selling, General & Administrative11.682.991.641.140.83
Operating Expenses11.682.991.641.140.83
Operating Income-10.73-1.160.040.400.20
Other Income/Expense
Interest Income0.000.010.000.000.00
Interest Expense-0.62-0.78-0.050.080.09
Other Income/Expense22.520.200.070.020.05
Income
Income Before Tax9.73-0.960.110.340.16
Income Tax Expense0.00-0.490.000.210.29
Net Income9.88-0.520.130.460.00
Net Income - Continuous Operations9.88-0.470.110.14-0.14
Net Income - Discontinued Operations-----
EBITDA-10.54-1.140.070.730.59
EBIT-10.73-1.160.040.420.24
Depreciation & Amortization0.190.020.030.300.34
Earnings Per Share
Basic EPS644.00-4164.002325.008190.00-3.00
Diluted EPS9.00-4164.002325.008190.00-3.00
Basic Shares Outstanding0.020.000.000.000.00
Diluted Shares Outstanding1.080.000.000.000.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NewGenIvf Group Financial Statements

What was NewGenIvf Group's revenue in fiscal 2025?

NewGenIvf Group reported revenue of $4.73M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 13.0% from $5.43M a year earlier.

Is NewGenIvf Group profitable?

Yes. NewGenIvf Group earned net income of $9.88M in fiscal 2025, a net margin of 209.0%. In fiscal 2024 it lost $524.64K.

What is NewGenIvf Group's operating margin?

NewGenIvf Group's operating income was −$10.73M on revenue of $4.73M in fiscal 2025, an operating margin of -226.9%, compared with -21.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition